FDA decision: Anitocabtagene Autoleucel (anito-cel) by Gilead Sciences (this year)
As of Sun, 20 Sep 2026 12:03:12 UTC, Kalshi traders price Yes (89.0%). The market has $4K in volume and closes on Fri, 01 Jan 2027.
Updated:
Current odds
| Outcome | Chance | Yes price | No price |
|---|---|---|---|
| Yes | 89.0% | 89.0¢ | 11.0¢ |
Market details
- Venue: Kalshi
- Volume: $4K
- Liquidity: $4K
- Closes:
Sources
Related markets
- S&P close price end of 2026?
- Nasdaq-100 price on Sep 30, 2026 at 4pm EDT?
- Nasdaq-100 close price end of 2026?
- Who will successfully take over Warner Brothers?
- When will Anthropic officially announce an IPO?
- When will Apple release the iPhone 18?
DOXA is a liquidity aggregator for prediction markets that compares odds and depth across Polymarket, Kalshi and others and routes each trade for best execution with an AI assistant.